Table 2 Information on primary urinary tract transitional cell carcinoma
Characteristics | No. of patients |
|---|---|
Primary site | |
Urinary bladder | 28 (76%) |
Renal pelvis | 2 (5%) |
Multiple tumor in both bladder and renal pelvis or ureter | 7 (19%) |
Pathologic stage of primary TCC* | |
0a,0is,I | 10 (40%) |
II | 2 (8%) |
III | 4 (16%) |
IV | 1 (4%) |
Unknown | 8 (32%) |
Histologic grading of primary TCC | |
G1 | 3 (8%) |
G2 | 11 (30%) |
G3 | 11 (30%) |
Unknown | 12 (32%) |
Treatment for TCC | |
TUR-Bt | 23 (62%) |
Cystectomy | 7 (19%) |
Nephroureterectomy | 6 (16%) |
Cystectomy and nephroureterectomy | 1 (3%) |
Interval between treatment for TCC and detection of pulmonary lesion (months) | |
0 (synchronous) | 5 (14%) |
< 24 | 10 (27%) |
24–60 | 10 (27%) |
> 60 | 12 (32%) |
Urinary bladder relapse of TCC before lung resection | |
Yes | 8 (22%) |
No | 29 (78%) |